Clinical Trials Directory

Trials / Completed

CompletedNCT01881347

Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus

Randomized Crossover Study of The Effects of Resveratrol on Endothelial Function in Subjects With Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Boston University · Academic / Other
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The present study is designed to test the hypothesis that resveratrol supplementation will improve the function of the endothelium in patients with type 2 diabetes mellitus. The function of the endothelium will be tested with a non-invasive technique that uses ultrasound to measure the amount of dilation that occurs in the brachial artery following 5-minute cuff occlusion. To help us understand potential mechanisms of benefit, we will also collect blood, urine, and cell samples and test the effects of treatment on protein expression, nitric oxide production, and function of mitochondria.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTResveratrolResveratrol 100 mg daily for 2 weeks followed by resveratrol 300 mg daily for 2 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo 100 mg daily for 2 weeks followed by placebo 300 mg daily for 2 weeks.

Timeline

Start date
2013-01-01
Primary completion
2015-03-01
Completion
2016-07-01
First posted
2013-06-19
Last updated
2018-03-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01881347. Inclusion in this directory is not an endorsement.